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R E S E A R C H A R T I C L E
Genome-Wide Identification of Basic Helix–Loop–Helix
and NF-1 Motifs Underlying GR Binding Sites in
Male Rat Hippocampus
John R. Pooley,1 Ben P. Flynn,1 Lars Grøntved,2 Songjoon Baek,3
Michael J. Guertin,4 Yvonne M. Kershaw,1 Matthew T. Birnie,1 Annie Pellatt,1
Caroline A. Rivers,1 R. Louis Schiltz,3 Gordon L. Hager,3 Stafford L. Lightman,1
and Becky L. Conway-Campbell1
1Henry Wellcome Laboratories for Integrated Neuroscience and Endocrinology, University of Bristol, Bristol
BS1 3NY, United Kingdom; 2Department of Biochemistry and Molecular Biology, University of Southern
Denmark, 5230 Odense, Denmark; 3Laboratory for Receptor Biology and Gene Expression, National Cancer
Institute, National Institutes of Health, Bethesda, Maryland 20892; and 4University of Virginia School of
Medicine, Charlottesville, Virginia 22908
Glucocorticoids regulate hippocampal function in part by modulating gene expression through the
glucocorticoid receptor (GR). GR binding is highly cell type specific, directed to accessible chromatin
regions established during tissue differentiation. Distinct classes of GR binding sites are dependent
on the activity of additional signal-activated transcription factors that prime chromatin toward
context-specific organization. We hypothesized a stress context dependency for GR binding in
hippocampus as a consequence of rapidly induced stress mediators priming chromatin accessibility.
Using chromatin immunoprecipitation sequencing to interrogate GR binding, we found no effect of
restraint stress context on GR binding, although analysis of sequences underlying GR binding sites
revealed mechanistic detail for hippocampal GR function. We note enrichment of GR binding sites
proximal to genes linked to structural and organizational roles, an absence of major tethering
partners for GRs, and little or no evidence for binding at negative glucocorticoid response elements.
A basic helix–loop–helix motif closely resembling a NeuroD1 or Olig2 binding site was found
underlying a subset of GR binding sites and is proposed as a candidate lineage-determining
transcription factor directing hippocampal chromatin access for GRs. Of our GR binding sites,
54% additionally contained half-sites for nuclear factor (NF)-1 that we propose as a collaborative or
general transcription factor involved in hippocampal GR function. Our findings imply a dose-
dependent and context-independent action of GRs in the hippocampus. Alterations in the ex-
pression or activity of NF-1/basic helix–loop–helix factors may play an as yet undetermined role in
glucocorticoid-related disease susceptibility and outcome by altering GR access to hippocampal
binding sites. (Endocrinology 158: 1486–1501, 2017)
The hypothalamic–pituitary–adrenal (HPA) axis re-sponds to stress with a delayed secretion of gluco-
corticoids promoting structural and neurochemical
changes within the brain that subserve the adaptive re-
sponse to stress, but can also contribute to maladaptation
resulting in disease states (1, 2). HPA axis abnormalities
are well described as underlying features of a number of
neuropsychiatric and neurodegenerative conditions, in-
cluding major depression (3), posttraumatic stress dis-
order (4), social phobia (5), Huntington disease (6), and
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Alzheimer’s disease (7). These abnormalities may influ-
ence susceptibility to disease states (8) or contribute to the
severity of clinical symptoms (9). Thus, understanding
the mechanisms for glucocorticoid actions in the brain is
an essential goal.
The glucocorticoid receptors (GRs) and mineralo-
corticoid receptors have genomic roles as ligand-
dependent transcription factors that bind DNA and
coordinate the regulation of gene expression networks in
response to glucocorticoid (10–12). In this study, we focus
on GRs, the dysfunction of which is thought to underlie
altered negative feedback and HPA axis hyperactivity in
major depression (13). Three forms of DNA binding have
been described for GRs: direct DNA interaction at variants
of the consensus glucocorticoid response element (GRE)
motif 50-ACAnnnTGT(T/C)CT-30 (14, 15), direct DNA
binding to negativeGREs of variable sequence (16, 17), and
indirect DNA binding through tethering of GRs to other
transcription factors (18).
GR binding to GREs in hippocampus chromatin is
incompletely understood, although chromatin organi-
zation reflects a restrictive environment for signal-
activated transcription factors such as GR (19–21),
and it accounts for transcription factors accessing only a
small percentage of the total number of candidate DNA-
binding motifs genome-wide (22). Access is “granted” by
local remodeling and posttranslational modification of
chromatin into accessible regions known as DNase I hy-
persensitive sites (DHSs) (23, 24).On average, there are tens
of thousands of DHS-defined accessible regions in a cell
type, generated and maintained by transcription factor–
mediated recruitment of adenosine triphosphate–dependent
remodeling proteins and histone-modifying enzymes that
collectively modify nucleosome positioning and bio-
chemical properties (25, 26). Transcription factor binding
occurs almost exclusively at these regions of open and
accessible chromatin (27, 28).
Crucially, the vast majority (up to 95%) of DHSs are
preaccessible, that is, present prior to signal-dependent
transcription factors such asGRs becoming activated (27,
29, 30). It is becoming increasingly evident that pre-
accessible DHSs arise due to remodeler recruitment via
trans-acting factors that have been termedpioneers (31–35),
licensing factors (33), initiators (36, 37), or lineage-
determining transcription factors (LDTFs) (38–43). De-
spite the lack of naming consensus, it is generally accepted
that these factors act to initiate chromatin access in a highly
cell type–specificmanner. Consequently,GRbinding events
and glucocorticoid actions are also highly cell type–specific
delivered by the different accessible chromatin landscape
for each cell type (21, 29, 37, 43, 44). As factors regulating
cell type–specific chromatin access impact on enhancer
selection, subtle changes in their expression and activity
may be important in disease processes. Therefore, identifi-
cation of factors influencing GR chromatin access in brain
tissue may open new avenues of investigation for multiple
disease states.
Glucocorticoid actions within the same cell, or body
of cells, can also be context specific. Glucocorticoid-
dependent facilitation of emotionally salient memory
consolidation and retrieval requires activation of GRs in
the amygdala and prefrontal cortex (PFC) but also
noradrenergic signaling within the amygdala (45). Cor-
ticosterone enhancement of contextual fear memory
consolidation in songbirds depends on the activation of
hippocampal dopamine D1 receptors (46), whereas long-
term potentiation is impaired in the hippocampus in a
manner requiring glucocorticoids and the amygdala after
stress (47). Interestingly, several cell line studies dem-
onstrate an interplay with the accessible chromatin
landscape as a mechanism for context-dependent glu-
cocorticoid activity. GR activation contributes a de novo
chromatin remodeling role, allowing coactivated estro-
gen receptors (ERs) to bind into genomic locations
inaccessible to ERs when activated alone (48). To a lesser
extent, ERs mediate chromatin access for coactivated
GRs. Similar mechanisms likely explain the genome-wide
redistribution of GR binding sites when GRs are coac-
tivated with nuclear factor kB (49) or signal transducer
and activator of transcription 3 (50). Effects on gene
expression in the latter studies indicate a novel mecha-
nism by which context can impact gene regulation within
the same cell type. This mechanism may also account for
differential transcription in neuroblastoma cells cotreated
with dexamethasone and a m-opioid receptor agonist
compared with either ligand alone (51).
Continuing this line of investigation into animal tis-
sues, signaling convergence is proposed to coordinate
cross-talk between pathways necessary for stress-induced
alterations in behavior and physiology (52). Many
stress-induced alterations in brain signaling are rapid
(milliseconds to seconds) compared with circulating
glucocorticoids that peak with GR activity 30 minutes
following restraint stress initiation (53, 54). This delay
may allow rapid mediators of the stress response to
prime the hippocampus for glucocorticoid signaling (52).
We hypothesized that priming might involve re-
organization of chromatin downstream of early stress
mediators, redistributing GR binding and possibly gov-
erning some context-dependent physiological glucocor-
ticoid actions. We examine GR occupancy genome-wide
in the rat hippocampus for evidence of stress context
redistribution of GR binding, finding that GRs actually
occupy the same sites independently of context. Context
was controlled by infusing corticosterone into adrenal-
ectomized male rats while one group was subjected to a
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30-minute restraint stress, whereas another group
remained in the home cage [nonstressed control (NSC)].
Duplicate samples for each group additionally allowed
for interrogation of candidate motifs underlying hippo-
campal GR binding sites. GR binding was discovered near
genes linked to structural and organizational roles in the
hippocampus. Mechanistic insights into GR function were
derived from analysis of sequences underlying GR binding
sites, including that tethering and binding at negative
glucocorticoid response elements are not major contribu-
tors to GR–DNA interaction in the hippocampus. Binding
is instead centered at GREs or their half-sites, supported by
neighboring basic helix–loop–helix (bHLH) and nuclear
factor (NF)-1 half-site motifs. NF-1 proteins are ubiquitous
transcription factors characterized by the ability to act as
both transcription and viral replication factors.
Materials and Methods
Animals and treatment
All animal procedures were performed in accordance with
the revised UK Animals (Scientific Procedures) Act of 1986 and
European Union Directive 2010/63/EU. Adult male Sprague-
Dawley rats (225 to 250 g) had food and water ad libidum and
were used to avoid complications with estrous, ER, or pro-
gesterone receptor activities that may influence GR function in a
different context to the one tested. Rats received balanced
anesthesia using veterinary isoflurane (Merial Animal Health,
Woking, UK) prior to bilateral adrenalectomy and implantation
of two right jugular venous polythene cannula for simultaneous
blood sampling and infusion (55). Animals recovered for 5 days
postsurgery on 15 mg/mL corticosterone in 0.9% saline drinking
solution to maintain isotonic levels, which was replaced 12 hours
prior to experiments with 0.9% saline.
All animals received infusions of corticosterone (0.75mg/mL
in the form of corticosterone 2-hydroxypropyl-b-cyclodextrin;
Sigma-Aldrich, Gillingham, UK) dissolved in sterile 0.45% (w/v)
NaCl. A New Era NE-1800 computer-driven infusion pump
(World Precision Instruments, Aston, UK) delivered 1 mL/h
for 30 minutes via one indwelling cannula to mimic the
endogenous rise in corticosterone observed following re-
straint stress (53).
Validation of experiment model
Animals were randomly assigned to NSC or stressed groups.
Animals in the NSC groupwere left in their home cages whereas
stressed group animals were restrained in Perspex cylinders for
30 minutes. Blood samples were taken via the second jugular
cannula immediately before infusion (0 minutes), and at 10, 20,
and 30 minutes into the infusion. Blood was collected into ice-
cold heparinized tubes with 2500 kIU aprotinin (Trasylol;
Bayer, Leverkusen, Germany).
Tissue collection for chromatin immunoprecipitation
sequencing experiments
After infusion, animals were euthanatized with 0.2 mL
intravenous sodium pentobarbital via the second cannula.
Whole hippocampus was dissected on ice for chromatin
immunoprecipitation (ChIP), and PFC was removed and
snap frozen in liquid nitrogen for quantitative reverse
transcription polymerase chain reaction. Trunk blood was
collected into ice-cold heparinized tubes for corticosterone
measurement.
GR ChIP sequencing
Hippocampiwere fixed for ChIP and processed to chromatin
in sodium dodecyl sulfate (SDS) lysis buffer [2% SDS, 10 mM
EDTA, 50 mMTris-HCl (pH 8.1)] as previously described (56).
Chromatin was sheared with a Sonifier 450 (Branson Ultra-
sonics, Danbury, CT; 123 10-second pulses at 10% output
with 30 seconds on ice between pulses) and then cleared of
cellular debris by centrifugation.
Each unique sample was composed of chromatin from eight
hippocampi pooled together, divided, and processed as 15
separate 100-mg ChIP reactions. For each reaction, chromatin
was diluted 1:10 in ChIP dilution buffer [167 mM NaCl,
16.7 mM Tris-HCl (pH 8.1), 1.1% Triton X-100, 1.2 mM
EDTA, 0.01% SDS] supplemented with cOmplete protease
inhibitor (Sigma). Chromatin (1%) input was collected and
stored at 220°C until required. Reactions were immunopre-
cipitated overnight at 4°C with 2 mg anti-GR M-20 X (Santa
Cruz Biotechnology, Dallas, TX), 4mL anti-GR PA1-510A, and
4 mg anti-GR PA1-511A antiserum (both Thermo Fisher,
Gloucester, UK). Antibody details are provided in Supplemental
Table 1.
GR–DNA complexes collected onto protein A–conjugated
Dynabeads (Invitrogen, Paisley, UK) were washed to remove
nonspecific binding. Purified DNA was resuspended in water
and samples for each group were concentrated into 30-mL
volume with a Univapo vacuum concentrator (Transcriptomics
Facility, University of Bristol). Two replicate ChIP and matched
input samples per group underwent library preparation
and sequencing on a GA2x using the Illumina platform at
the National Cancer Institute Advanced Technology Center
(Rockville, MD).
NF-1 association with GR binding sites
ChIP performed as described above with sonication time
reduced to 33 10-second pulses at 10% output. Two mi-
crograms of anti NF-1 H-300 (Santa Cruz Biotechnology)
was used to ChIP 40 mg of chromatin. Equivalent amounts
of nonimmune rabbit IgG (Santa Cruz Biotechnology)
provided controls. Supplemental Table 2 lists quantitative
polymerase chain reaction primers used to validate en-
richments at specific sequences identified by ChIP se-
quencing (ChIP-seq).
ACTH and corticosterone assays
Radioimmunoassay for plasma corticosterone and immu-
noradiometric assay for ACTH (Diasorin, Wokingham, UK)
were performed as previously described (57) except for a 1:4
dilution of plasma in 0.9% saline for ACTH assays.
PFC c-fos induction
Total RNA was extracted from rat PFC by the phenol–
guanidine isothiocyanate–chloroform method as previously
described (56) and further purified using an RNeasy kit with on-
column DNase digestion according to the manufacturer’s in-
structions (Qiagen, Manchester, UK). One microgram of total
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RNA was converted to complementary DNA using an AMV
first-strand synthesis kit (Invitrogen) and c-fos expression
quantified by quantitative reverse transcription polymerase
chain reaction using a TaqMan primer-probe assay (no.
Rn02396759_m1; Applied Biosystems, Warrington, UK) on an
ABI Prism 7500 detection system (Applied Biosystems). Data
were normalized to the b-actin housekeeping gene (assay ID
4352931E; Applied Biosystems), and relative expression was
analyzed by the DDCt method.
Statistical analysis
Hormone levels in blood samples taken over the time course
were analyzed using repeated measures analysis of variance
(ANOVA) with Petersen replacements (58) for missing values.
Significant main effects were reported with Greenhouse–
Geisser correction for unequal variance when necessary. Post
hoc testing used a Wilcoxon signed-rank test between time
points or a Mann–Whitney U test between groups, with each
Bonferroni adjusted for multiple comparisons. End-point cor-
ticosterone levels and PFC c-fos expression were both compared
using two-way ANOVA.
ChIP-seq data analysis
Alignment to the rn5 reference genome was performed using
Bowtie2. Tags were extended to 150 bp in their 30 direction, and
duplicated tags were removed, eliminating polymerase chain
reaction bias. Tag density was normalized to the appropriate
input controls, and simple repeats were masked for replicate
concordant peak calling using an in-house algorithm Hotspot
(27, 34, 59). Significantly enriched genomic regions common to
both replicates were ranked by tag density, and the top 20% in
each group were carried through to additional analysis. GR
peaks were visualized in the University of California Santa Cruz
Genome Browser (60) with groups normalized to sequencing
depth (number of tags per 10 million total reads). DAVID gene
ontology was used to explore the functional relationship of
likely GR targets (61).
HTSeq (62) counted raw tags at GR binding sites before
DESeq (63) compared peak intensities statistically. After
adjusting for the number of comparisons, P values of ,0.05
were taken as significant. HOMER Analysis Suite v4.7 (39)
annotated GR peaks to their nearest transcription start site.
Promoters were defined as25 kb to +100 bp to report genomic
locations of GR binding sites. GR binding sites were arranged
according to maximum tag density before HOMER counted
raw tag density 3 kb either side of the peak center. Data were
exported to MeV version 4-8-1 (Dana–Farber Cancer Institute,
Boston, MA) for heat map generation.
GR binding sites were analyzed for known and de novo
motifs using HOMER. Repeat sequences were masked and
motifs were optimized around 6, 8, 10, 12, 14, and 16 bp.Motif
counting data using known motif files and histograms in-
dicating motif positions relative to the peak center were pro-
duced in HOMER.Motif files matching the three variants of the
consensus sequence for negative GREs, 50-CTCC(N)0-2GGAGA-30
(17), were created using motif editor allowing only exact matches
to the negative GRE (nGRE) consensus.
GEO accession GSE46047 provided DHS sequencing (DHS-
seq) and GR ChIP-seq peak annotations for adrenalectomized
mouse liver. Assay for transposase-accessible chromatin se-
quencing (ATAC-seq) data for neuronal subtypeswere available
under GEO accession GSE63137. DHS sequencing (DHS-seq)
data for human primary astrocytic cells (HA-h, HA-c, HA-sc)
and for the human neuronal SK-N-MC cell line were obtained
from the ENCODE database. GEO accession GSE61236 pro-
vided DHS-seq and GR ChIP-seq peak annotations for 3134
cells with and without corticosterone treatment.
Results
Validation of experimental design
This study was designed to investigate the potential for
context-dependent alterations in GR binding in the rat
hippocampus. Robust validation of the experimental
design was required to ensure well-matched corticoste-
rone levels while additionally maintaining basal HPA
axis activity in one group but activating the central stress
pathways in the second group.
Circulating corticosterone levels increased in both
groups during the infusion [significant effect of time;
F(2.33,137.6) = 54.1, P , 0.0001]. There was no sig-
nificant interaction of time3 group [F(2.33,137.6) = 0.51,
P = 0.629] and no effect of group [F(1,59) = 2.58,
P = 0.113], indicating that corticosterone levels were
consistent across groups [Fig. 1(a)].
Plasma ACTH showed significant main effects of time
[F(2.21,130.1) = 35.0, P , 0.0001)] and of group
[F(1,59) = 42.2, P , 0.0001]. An interaction (time 3
group) F(2.21,130.1) = 9.75, P , 0.0001 indicated that
ACTH levels changed in both groups but with different
patterns [Fig. 1(b)]. Post hoc testing showed that ACTH
in stressed rats increased significantly 10 minutes fol-
lowing commencement of restraint (P = 0.001), dem-
onstrating activation of the central stress response.
ACTH then returned to prestress levels by 30 minutes
(P = 0.096). In the NSC group there was a small
but significant decrease in ACTH at 30 minutes
(P , 0.0001), but levels were otherwise stable. Impor-
tantly, both groups began with comparable ACTH levels
(P = 0.626), but the stressed group had higher ACTH at
all other time points (each P , 0.0001).
For the eight animals pooled per replicate for ChIP-
seq, there was no difference in trunk blood corticosterone
levels between groups [F(1,28) = 0.038, P = 0.847] or
between replicates [F(1,28) = 1.481,P = 0.234] [Fig. 1(c)].
PFC c-fos expression showed a significant effect of group
[F(1,28) = 318.0, P , 0.0001] but no effect of replicate
[F(1,28) = 0.193, P = 0.663] [Fig. 1(d)], indicating activation
of the central stress response (64) only in the expected group.
ChIP-seq detects previously known and novel GR
binding sites in rat hippocampus
Formaldehyde-fixed nuclei from whole hippocampus
(eight rats per replicate) underwent ChIP-seq for GR.
Replicate concordant peaks were ranked by their max-
imum tag density, and the strongest 20% (highest number
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of tags) for each group were selected for downstream
analysis. Examples of the 7298 total genomic regions
containing GR binding sites in stressed and NSC rat
hippocampi are shown in Fig. 2. Binding sites previously
described in hippocampus [Fig. 2(a–c)] as well as novel
target sites for GRs [Fig. 2(d–f)] were observed. Se-
quencing files are available on National Center for
Biotechnology Information GEO DataSets under acces-
sion number GSE94008.
No apparent redistribution of GR binding sites in the
context of restraint stress
To test for changes in hippocampal GR binding genome
wide related to the context of stress exposure, the tag density
between NSC and stressed groups were compared at all
peak chromosome positions. Figure 3(a) indicates that
peaks have highly similar tag densities between groups
(Pearson correlation 0.920, P , 0.0001). DESeq analysis
using both replicates from each group revealed that no
peaks had significantly different tag densities between groups
[log ratio (M) versus mean average (A) plot, Fig. 3(b)]. A
heat map displaying all the chromosome positions ranked
by peak tag density [Fig. 3(c)] enabled clear visualization of
the lack of differences between the two groups. All
nonduplicated genomic positions were therefore pooled
for further analysis (Supplemental Table 3).
Distribution of GR binding sites
GR binding site distribution was examined by anno-
tating chromosomal position relative to the nearest gene
transcription start site. As has been observed previously
for GRs in the rat hippocampus (65), most GR binding
occurred in intergenic regions or within introns [Fig. 3(d)].
Fewer binding events were observed in promoters, 30 or 50
untranslated regions or exons.
To uncover hippocampal genes that may be influenced
by activated GRs, we isolated 3165 binding sites located
inside a gene body (intron, exon, or untranslated region)
or the extended promoter region (upstream to 25 kb).
Gene ontology analysis revealed significant enrichments
Figure 1. Validation of experimental design. (a) Plasma corticosterone measured prior to the start of the infusion (0 minutes) and at 10, 20, and
30 minutes thereafter. Blood samples were drawn by hand through indwelling cannulas. Corticosterone rises after the start of the infusion and
does not differ between NSC (black circles, n = 30 to 31) and stressed (gray squares, n = 17 to 20) groups. (b) Plasma ACTH levels rose in
stressed group rats, in line with activation of the central stress response. #P , 0.0001 (between groups); *P , 0.005 (different from 0 minutes).
n = minimum of 30 (NSC) or 17 (stressed). (c) Plasma corticosterone in trunk blood for animals taken for ChIP-seq. All animals received similar
corticosterone infusions regardless of group or replicate (one-way ANOVA, n = 8 per replicate). (d) PFC c-fos expression is significantly different
between groups. The two stressed group replicates have higher c-fos levels compared with either NSC group. #P , 0.0001 (compared with NSC
replicates), n = 8. NSC replicates were not different from each other, and stressed replicates were not different from each other. Means 6
standard error of the mean are shown.
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for 480 biological function categories (Supplemental
Table 4) and 146 significantly enriched molecular
functional categories (Supplemental Table 5). These data
suggest that glucocorticoid hormones, via GRs, influence
the regulation of genes disproportionally linked to the
molecular processes of ion binding, phosphorylation,
cytoskeleton, and voltage-gated channel activity. Func-
tional annotations include regulation of development,
morphogenesis, and organization of cells of the central
nervous system and their projections in addition to the
transmission of electrical information between cells.
Identification of candidate trans-acting factors
contributing to GR binding in rat hippocampus
In the absence of stress context–dependent GR
binding in rat hippocampus, we postulated that stress-
activated transcription factors were not involved in
either redefining the hippocampal accessible chromatin
landscape in this time frame or acting as a major GR
tethering partner. DNA sequences underlying GR binding
sites in both the present study and that of Polman et al. (65)
were subjected to de novo motif analysis to interrogate
which DNA binding motifs were enriched at hippocampal
GR binding sites.
The most significant de novo motif discovery for our
data set was similar to the GRE (similarity score 97%)
and was present in 49% of all GR peaks. A motif
resembling a GRE half-site (score 73%, 61.2% of all
peaks) was also a significant finding in our data set. A
motif closely resembling the NF-1 half-site (score 93%,
54.6% of all peaks) and a motif matching a bHLH
transcription factorwere additionally enriched (17.1%of
Figure 2. GR ChIP-seq in rat hippocampus reveals known and unknown GR binding sites. (a–f) Browser tracks showing regions of interest in the
genome. Tag density profiles are shown for each group indicating regions called as GR-bound peaks. Known genes (RefSeq) are indicated along
with the direction of the coding strand (chevron). (a and b) Promoter region for the clock gene period 1 (Per1) known to contain binding sites for
GRs in rat hippocampus (56), and the promoter region of metal ion chelator metallothionein-2a (108). (c) The upstream region of the Ddit4 gene
also known to contain GR binding sites. The presence of these known sites within the peak list highlights the success of the experimental protocol.
(d–f) Novel GR binding sites in the hippocampus. Several locations flanking the calcium-calmodulin–dependent kinase 2a (Camk2a) gene and the
promoter of the thyroid hormone receptor a (Thra) gene bind GRs. A weaker intronic binding site is also observed in the Bdnf gene.
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all peaks). The latter motif best matched the consensus
DNA binding site for the transcription factor NeuroD1
(score 94%), as well as displaying a high degree of
similarity to the consensus motif of the related Olig2
(score 89%) [Fig. 4(a)]. Similar motifs were obtained
from the high confidence peak list of Polman et al. (65)
when reanalyzed using the same parameters as our own
data [Fig. 4(b)]. A principal difference in the reanalyzed
data set was the GRE half-site motif,
which was weakly represented and
degenerate relative to that discovered
in our GR binding sites. Non–GRE
motifs occurring in GR binding sites
were located toward the center of GR
binding [Fig. 4(c)] but displayed a
broader distribution from the peak
center than did GREs, suggesting more
positional flexibility.
A common tethering factor for GR
in hippocampus would be expected to
present a distinct motif. Of our total
identified GR binding sites, 3997 did
not contain a fully palindromic GRE
and were separated from those that did
for additional analysis. De novo motif
analysis of these two subsets of
peaks—group 1 containing a full GRE
and group 2 absent a full GRE—pro-
duced additional motifs with moderate-
high confidence matches to known
transcription factor binding sites
(Supplemental Fig. 1). Nonetheless,
motif frequency analysis for peaks in
these two groups produced highly
similar findings [Fig. 4(d)]. Of peaks
absent a full GRE, 81.6% contained
GRE half-sites that likely supported
GR binding. Overall, 89.9% of all GR
binding sites contained some form of
GRE. Further analysis of 735 GR
binding sites that contained neither a
full GRE nor a GRE half-site did not
yield any additional consensus motifs.
We next explored whether there
might be functional significance asso-
ciated with the motifs overrepresented
within the entire set of hippocampal
GR binding sites. It is now quite well
established that the accessible chro-
matin landscape of each different cell
type depends on transcription factors
classically referred to as pioneers (35),
and more recently as initiators (36).
The behavior of such factors shares similarities with
LDTFs proposed by others (39). As both LDTFs and
pioneers define accessible chromatin, their DNA recog-
nition sequences commonly occur within accessible sites.
Because most GR DNA binding occurs in preaccessible
sites (27), motif analysis of GR binding sites also recovers
pioneers/LDTFs (37, 66). We amalgamated these con-
cepts and present this relationship by reanalyzing
Figure 3. (a) Scatter plot of the log2 of peak intensity at the same chromosome position in
NSC and stressed groups. (b) Log ratio (M) versus mean average (A) plot for NSC and
stressed peaks. Peaks significantly different between groups were set to display as red dots.
There are no peaks significantly different between groups by DESeq. (c) Heat map
plotting tag density over the center of the peak (63 kb) supports the view that GR
binding is not significantly different between groups. Peaks are ranked according to their
tag density. (d) Distribution of hippocampus GR binding sites across the genome
annotated according to nearest transcription start site. Most binding events occurred in
intergenic or intronic regions with comparatively little occurring at promoters or within
coding regions. UTR, untranslated region.
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published GR binding (ChIP-seq) and accessible chro-
matin (DHS-seq) data from cell line 3134 andmouse liver
(37, 67). As most GR binding sites are within pre-
accessible chromatin [Fig. 5(a) and 5(c)] defined by
LDTFs, many GR binding sites also possess motifs for
putative LDTFs [Fig. 5(b) and 5(d)]. Taken together,
these data imply that NF-1 half-sites and NeuroD1/Olig2
motifs underlying hippocampus GR binding sites might
reflect LDTFs for the multiple cell types comprising the
hippocampal formation.
We therefore tested whether there was any evidence
for greater GR enrichment at sites containing NF-1/bHLH
Figure 4. Motif analysis identifies candidate binding partners for GRs in rat hippocampus. (a) De novo motif analysis of DNA sequences
underlying GR peaks in rat hippocampus returns motifs that strongly resemble a palindromic GRE, NF-1 half-site, and a basic helix–loop–helix
transcription factor most likely NeuroD1 or Olig2. The P value shows significance level for the enrichment of the motif indicated. The score
indicates the similarity of the identified motif to the known motifs for the factor indicated, with higher percentages equivalent to greater
confidence in an accurate match. The percentage of peaks containing motifs that match this model is also indicated (percentage targets). s.p.,
specific probability. (b) GR binding sites in rat hippocampus identified with high confidence by Polman et al. (65) were additionally examined by
de novo motif discovery using the same settings as above. A motif matching a GRE half-site (underline) was more degenerate and poorly
represented within peaks overall. (c) Motifs for the factors identified are located toward the center of the GR binding site. (d) The frequency of
discovered motifs was separately determined for GR peaks containing a fully palindromic GRE, and for the remaining GR peaks that did not
contain a GRE palindrome. By default, all GR peaks containing a full GRE also contained a GRE half-site, and so this was not determined (nd) for
the full GRE containing population. Most peaks absent a full GRE contained a GRE half-site instead.
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Figure 5. Overlap of GR binding sites (with dexamethasone or corticosterone) with preaccessible chromatin defined by DNase I hypersensitivity
(without dexamethasone or corticosterone) in the (a) 3134 mammary carcinoma cell line, and (c) in adrenalectomized mouse liver. Redrawn from
data in Stavreva et al. (67) and Grøntved et al. (37), respectively. De novo motif discovery for DHS peaks and GR binding sites in (b) 3134 cells, or
(d) mouse liver, produces many of the same motifs. Motifs are arranged in order of significance with P values for DHS motifs between 1e-7713
and 1e-42, and P values for GR binding site motifs between 1e-2918 and 1e-53. All motifs indicated have a confidence score of .80%. (e) GR
binding enrichment was determined by ordering peaks according to tag density and counting motifs in the top and bottom third, respectively.
Weaker peaks have fewer occurrences of transcription factor motifs. GREs, NF-1 half-sites, NeuroD1, Olig2, Atoh1, Lhx3-like, AP-1, and Egr2
motifs particularly are less well represented in weaker GR binding sites. Conversely, GRE half-sites and myocyte enhancer factor 2 motifs are
better represented in weaker binding sites. (f) Composite motifs containing GREs, NF-1, and NeuroD1/Olig2 are more common in stronger peaks
whereas weaker binding sites are more likely to contain isolated GRE sequences. GRE/H, full GRE or GRE half-site; NF-1-H, NF-1 half-site; ND1,
NeuroD1; O2, Olig2. (g) ChIP assay showing the presence of NF-1 at four out of five selected GR binding sites in rat hippocampus is not
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motifs, as was reported for GRs in liver at binding sites
containing CCAAT/enhancer-binding protein (37). Con-
sistent with the dynamic assisted loading mechanism
proposed to account for this observation in liver (36, 68),
NF-1/bHLH motifs were more frequently associated with
highly enriched (strong) GR binding sites vs weaker sites
[Fig. 5(e)]. This effect was also quite marked for AP-1 and
Egr2, although these motifs occurred in considerably
fewer peaks.We next examined the frequency of composite
sites—NF-1 half-sites and NeuroD1/Olig2 motifs with
GREs—in strong and weak GR binding sites [Fig. 5(f)].
Fully palindromic GREs or GRE half-sites occurred alone
more commonly in weak peaks compared with strong,
whereas strong peaks more frequently contained combi-
nations of GREs with the additional motifs.
Most GR binding sites are within preaccessible chro-
matin defined byLDTFs [Fig. 5(a–d)] and accessible prior to
hormone treatment. Thus,wemight expect that recruitment
of candidate LDTFs NF-1 and NeuroD1/Olig2 would not
be hormone-dependent at a large majority of sites.
Choosing to focus on NF-1 for which a suitable antibody
was available, ChIP assay revealed that the presence of
NF-1 was not dependent on corticosterone or GR activity
at four out of five GR binding sites [Fig. 5(g)].
As hippocampus contains many different cell types,
we have investigated which cell types are most likely
responsible for each motif obtained. Separate de novo
motif discovery on ENCODE DHS-seq data for three
populations of human primary astrocytes (hippocam-
pus, cortex, and spinal cord) revealed candidate LDTFs
mediating accessible chromatin in astrocytes. We noted
thatNF-1 half-sites were present in all three subtypes but
NeuroD1/Olig2 motifs were absent (Table 1). To our
knowledge, similar data for oligodendrocytes or
microglia are not yet available. ATAC-seq data for
purified populations of excitatory pyramidal neurons,
vasoactive intestinal peptide–expressing interneurons,
and parvalbumin-expressing interneurons from mouse
neocortex have been published (69). ATAC-seq pro-
vides similar information to DHS-seq, and de novo
motif analysis indicated that neuronal subtypes shared
several candidate LDTFs whereas others were unique to
neuron type (Table 1). A NeuroD1/Olig2 motif was
uniquely detected in excitatory pyramidal cell accessible
chromatin in addition to 17.1% of hippocampus GR
binding sites. Variant bHLH motifs were detected in in-
terneurons but more closely matched other bHLH tran-
scription factors whereas Lhx2 was unique to vasoactive
intestinal peptide–expressing interneurons. NF-1 half-sites
were again detected in all primary neuronal subtypes,
appearing in a greater percentage of accessible chromatin
sites compared with astrocytes.
Little support for GR binding at putative
negative GREs
Previous reports suggest GR binding at nGRE motifs
within genes related to the HPA axis and circadian
regulation (17, 70). The hippocampus is well associated
with HPA axis regulation (71), and we identified 126
hippocampal GR peaks containing nGRE sequences.
Analysis revealed that all but six sites also contained
palindromic or half-site GRE sequences that were on
average closer to the peak center than the nGREs (Sup-
plemental Fig. 2). Consequently, binding of GRs to most
sites containing nGREs appeared more likely mediated
through conventional GRE-like motifs. In the six sites
where no obvious GRE or half-site could be observed, the
nGRE was not central to the peak in five, suggesting that
another factor was responsible for GR binding. The
remaining site additionally contained the sequence 50-
GTCACAnnnAGTCCT-30, which, although a degenerate
motif, could conceivably bind GR.
Discussion
Absence of stress context in GR binding
In contrast to studies in cell lines where differential ac-
tivation of signal-dependent transcription factors causes a
marked redistribution of GR binding (48–50), we did not
detect any stress-dependent redistribution of GR binding in
the rat hippocampus. Various possible explanations might
explain this outcome in a brain region where multiple
signaling systems are influenced rapidly by the acute stress
response. One possibility may be the inherent differences
between cell lines and tissue. There is also considerable
cellular heterogeneity in the hippocampus. It is therefore
possible that a combination of these two factors—in vivo
tissue comprising a mixed cell population—contributes to
the inability to detect context-dependent GR binding al-
terations. As a consequence, potentially strong effects in
weakly represented cell types might be lost in the average
population. Alternatively, there is some evidence to sup-
port at least one major context-dependent glucocorticoid
action in the hippocampus being dependent on peripheral
adrenergic signaling (72), removed here by adrenalectomy.
Nevertheless, our data strongly indicate that in this
experimental protocol acute restraint stress does not
cause a redistribution of hippocampal GR binding sites.
Figure 5. (Continued). corticosterone/GR-dependent. Intergenic peak 1912 may be a de novo site requiring GR to recruit NF-1. The liver specific
Tat gene promoter does not recruit GRs in this tissue and is shown as a negative control for NF-1 binding. Means 6 standard error of the mean
are shown; n = minimum of 7 for all sites except the Tat-negative control, where n = a minimum of 3.
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This supports a conclusion that the GR binding profile in
the hippocampus is dose-dependent and not further mod-
ulated by concomitant activation of central stress-induced
signaling pathways. Therefore, it seemsmore likely that any
differential outcome in the behavioral and/or transcrip-
tional response to stress is mediated by post-GR binding
mechanisms. In support of this, transcription factors in-
duced by stress, including Fos (73–75), CREB downstream
of b-adrenergic receptor and CRH receptor signaling
(76–79), and factors downstream of extracellular signal-
regulated kinase and c-JunN-terminal kinase cascades (e.g.,
Elk1, Egr1, AP-1) (79–81), have been reported to exhibit a
delayed onset. Therefore, it is conceivable that stress-
associated changes might modify the chromatin land-
scape for subsequent stress exposure, thus providing a
mechanism for how stress history alters the transcriptional
response to glucocorticoid challenge (82).
GR binding sites may confer regulatory influence to
genes directing the production and organization of
neural cells and their projections
GR binding sites were distributed around the ge-
nome comparable to many transcription factors, and as
previously reported for hippocampal GRs (65). We
performed gene ontology analysis to identify any
functional significance that could be attributed to our
GR binding sites. In addition to pathways consistent
with neural GR actions, we found an enrichment of
genes associated with the development and organiza-
tion of cells of the nervous system. Related enriched
categories included cell adhesion, cell projection or-
ganization, neuron development and differentiation,
axonogenesis and synaptogenesis, and neuron pro-
jection development. Several structurally related genes
identified (e.g., Bdnf, Egfr, Fgf2, Mertk, and Cyfip1)
are regulated by glucocorticoids at the mRNA level in
hippocampus (82). Interestingly, some of these are
additionally known to be dysregulated in the hippo-
campus of human patients with neuropsychiatric dis-
orders (e.g., Bdnf, Fgf2) (83, 84). Stress maladaptation
in animal models produces defects in dendritic spine
morphology and numbers, neurogenesis, glial cell
density, and synapse formation (85–87). In stress-
related neuropsychiatric disease, postmortem studies
so far suggest similar findings (88–90), but may benefit
from further study.
Table 1. De NovoMotif Discoveries in Accessible Chromatin From Astrocytic and Neuronal Primary Cells and
From the SK-N-MC Neuronal Cell Line for Comparison
Motif Identified
(Score >85%)
Astrocytes Primary Neurons
Neuronal Cell Line
SK-N-MCHA-h HA-c HA-sc
Excitatory
Pyramidal
VIP
Interneuron
PV
Interneuron
AP-1 1e-757 (26.6%) 1e-820 (25.3%) 1e-1035 (29.9%) 1e-301 (20.2%) 1e-130 (18.4%) 1e-160 (18.1%) 1e-65 (10.2%)
CTCF 1e-327 (5.7%) 1e-641 (9.2%) 1e-443 (6.9%) 1e-271 (7.0%) 1e-291 (9.6%) 1e-343 (11.3%) 1e-738 (12.2%)
RUNX 1e-196 (19.1%) 1e-257 (25.0%) 1e-180 (18.3%) 1e-122 (9.7%)
NF-1 1e-186 (15.0%) 1e-175 (18.1%) 1e-182 (6.5%)
TEAD 1e-248 (20.4%) 1e-151 (16.4%) 1e-152 (18.3%)
NF-1 half-site/NFIC 1e-104 (16.5%) 1e-104 (24.9%) 1e-81 (17.5%) 1e-150 (47.8%) 1e-87 (47.6%) 1e-41 (60.4%)
REST 1e-59 (0.4%) 1e-37 (0.7%) 1e-38 (0.4%) 1e-49 (0.3%)
Rfx family 1e-92 (2.5%) 1e-69 (4.4%) 1e-105 (3.4%) 1e-27 (4.3%) 1e-43 (1.8%)
Smad3 1e-24 (18.0%)
Atf7 1e-83 (10.1%) 1e-71 (19.9%)
Egr2 1e-322 (27.5%)
bHLH NeuroD1/Olig2 1e-230 (21.9%) 1e-53 (7.5%)a
Mef2a/Mef2c 1e-148 (33.7%) 1e-73 (39.4%)b 1e-184 (24.0%)
NFIL3 1e-62 (9.1%) 1e-34 (10.4%)
bHLH Ap4/Ascl1/Tcf12 1e-192 (47.9%) 1e-107 (38.3%)
Lhx2 1e-124 (41.2%)
RORgt/RORA 1e-62 (7.0%)
ETS-like (Fli1) 1e-229 (20.3%)
C/EBP family 1e-92 (26.3%)
GC-box: Klf/Sp1 family 1e-53 (7.0%)
Motifs matching the indicated transcription factors with .85% scores indicate high confidence in accurate identifications. The P values indicate sig-
nificance for the motif enrichment within the data set, and in parentheses the percentage of total sites containing the indicated motif. For several factors
multiple candidate identifications aremade as themotif closely resembles each, or a family is indicated. SK-N-MC cells once described as a neuroblastoma
cell line share motifs with both astrocytes and neurons in addition to unique motifs not found in primary cells. bHLH transcription factors are categorized
according to motif. One group contains a motif (CAgATGG) that closely matches NeuroD1/Olig2 type transcription factors (lowercase indicates a more
flexible base). Another contains motif CAgcTG, which better matches Ap4- and Ascl1-type factors.
Abbreviations: C/EBP, CCAAT/enhancer binding protein; HA-c, human astrocyte of the cortex; HA-h, human astrocyte of the hippocampus; HA-sc, human
astrocyte of the spinal cord; PV, parvalbumin; VIP, vasoactive intestinal peptide.
aAmotif similar to the NeuroD1/Olig2 bHLH group is found in SK-N-MC cells but identification as TAL1 (score 89%)was preferred to Olig2 (86%) (column
heading, SK-N-MC).
bAn Mef2-type motif is present (column heading, VIP neurons), but the motif does not reach the .85% confidence level for identification as Mef2a/c.
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Mechanisms for hippocampal GR action
We found little evidence of nGRE usage whereas
89.9% of hippocampal GR binding sites contained some
form of GRE (full palindrome or half-sites). GR tethered
to another factor produces a narrow motif distribution
for that factor around the binding center (50). NF-1 and
NeuroD1 motifs were more broadly distributed from
peak centers than were GREs, and there is no existing
evidence for protein–protein interactions between GRs
and NF-1, NeuroD1, or Olig2. These motifs were found
alongside GREs or GRE half-sites rather than instead of
them. Taken together, these data indicate that tethering
of GRs to DNA-bound transcription factors is not a
major mechanism contributing to GR activity in the
hippocampus as it is for some cell types (50). Similar
conclusions were reached by others (65), although we
differ in our assessment of palindromic GRE usage.
Consistent with previous work in tissue (37), we detected
multiple sites supported by GRE half-sites whereas the
aforementioned work (65) did not. This might relate to
increased sequencing depth in our study. Weaker sites,
supported by GR half-sites, could potentially have been
missed due to less sequencing depth reported in the earlier
study (65). Indeed, our motif reanalysis of these pre-
viously reported peaks identified a weak match to a
degenerate half-site [Fig. 4(b)]. However, as 735 hip-
pocampus GR binding sites in the present work contain
neither full nor half GREs, we cannot rule out tethering
as a minor contributor to GR function, but no further
consensus motifs were enriched in this population.
Functional significance of transcription factor motifs
underlying GR binding sites
DNA sequences for hippocampal GR peaks contained
NF-1 half-sites and a motif reflecting a bHLH tran-
scription factor binding site. The latter was identified
computationally as NeuroD1 but could reflect Olig2 or a
variety of other similar transcription factors such as
Ascl1/Mash1, Olig1, Atoh1, Neurog2, and Hes (91, 92).
Our motif discovery shows a surprising lack of agree-
ment with candidate motifs identified in the only other
published hippocampal GR ChIP-seq data set (65), likely
due to differences in analysis. Accordingly, results from
our HOMER reanalysis of the previously published
hippocampal GR binding sites revealed the same motifs
as our own data set. Similar analyses in cells and tissues
reveal motifs for transcription factors involved in
establishing accessible chromatin during differentiation
that are described as pioneers or LDTFs (34, 37, 44, 66)
(Fig. 5). Factors that bind to the motifs underlying hip-
pocampal GR peaks might therefore be expected to have
clear links to neural cell differentiation and brain de-
velopment. Indeed, NeuroD1-deficient mice fail to
develop a hippocampal granule cell layer (93). Survival
and differentiation of adult born neurons from neural stem
cells also require NeuroD1 (94), and low NeuroD1
expression reduces neurogenesis (95). Knockout of related
Neurog2 also profoundly affects development of the den-
tate gyrus (96) whereas double-knockout ofOlig1/2 results
in total loss of oligodendrocytes throughout the brain (97).
Nfib and Nfix particularly contribute to hippocampus
formation development (98, 99), andmice heterozygous for
Nfix have highly abnormal hippocampal structure (100).
We show a broader tolerance of NF-1/NeuroD1/Olig2
motif positioning that need not be at the peak of GR
binding, and that stronger GR binding sites contain more
motifs for NF-1/NeuroD1/Olig2. Sample heterogeneity
appreciably complicates interpretation of the presence of
more motifs in stronger peaks, but the presence of NF-1
does not depend on GR activity at several sites [Fig. 5(g)],
consistent with a role for NF-1 in defining preaccessible
chromatin. As is the case for other pioneers, we hy-
pothesize that most sites would load NF-1 prior to
hormone and promote GR binding (44), although at a
small percentage of sites, NF-1 would require GRs to
access DNA (36) [e.g., intergenic peak 1912, Fig. 5(g)].
Taken together, our findings suggest that NF-1 and
NeuroD1/Olig2 support GR binding as candidate
LDTFs. An architectural role for NF-1 in GR binding has
been proposed by others (101), and similar mechanisms
may occur in the hippocampus. Nonetheless, we offer
only indirect evidence for NF-1 and NeuroD1/Olig2
involvement in establishing the accessible chromatin
landscape in hippocampal cell types.
Heterogeneity makes the identification of cell types
contributing to the NF-1 and NeuroD1/Olig2 motifs
observed challenging. A sizable portion of cells in the
present study were likely glial, consistent with a higher
proportion of glial cells compared with neurons (1.6- to
3.0-fold) in adult rat hippocampus (102). Neurons and
glia are further and extensively subdivided into a myriad
of different cell types for which there is little or no in-
formation regarding abundance. We exploited published
ATAC-seq and DHS-seq data sets reporting accessible
chromatin for neurons and astrocytes. Although data
from these methods are not absolutely concordant, both
approaches identify accessible chromatin and show good
overlap when applied to the same cell type (103).
All three types of neurons examined produced AP-1
and a bHLH factor motif in accessible chromatin. Only
excitatory neurons isolated by Camk2a-driven green
fluorescent protein expression (69) produced NeuroD1/
Olig2 as a candidate LDTF. This motif was not present in
any of the three types of astrocytes examined, suggesting
that NeuroD1 comes from excitatory neurons. How-
ever, as other cell types could not be studied (e.g.,
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oligodendrocytes, microglia), this determination is ten-
tative. Indeed, Olig2, a predominant transcription factor
determining oligodendrocyte fate (97), would be ex-
pected to bind this motif.
Notably, NF-1 half-sites detected at 54.6% of hip-
pocampus GR binding sites were also present at 47% to
60% of neuronal accessible chromatin sites, and at 16%
to 25% of accessible chromatin sites in astrocytes
(Table 1). This motif is also featured in the accessible
chromatin of the mouse liver (Fig. 5), but it is not present
in the accessible chromatin of neuronal SK-N-MC cells
(Table 1), and it does not underlie GR binding sites in
macrophages (66). Taken together, these results suggest
some degree of cell specificity in the role of NF-1 in
chromatin accessibility and GR binding. Therefore, de-
spite sharing some LDTF characteristics, NF-1may take a
different role, potentially acting as a common collabo-
rating or general trans-acting factor associated with
LDTFs (40, 43) at accessible chromatin in the hippo-
campus and other glucocorticoid-sensitive cell types.
Relevance to disease
Our data suggest that factors that influence the ex-
pression, activity, and binding of NF-1/NeuroD1/Olig2
transcription factors might be expected to impact hip-
pocampal GR binding and would be of interest in
glucocorticoid-related disease. By way of example, seipin
(Bscl2) knockout mice display a depressive phenotype
accompanied by reduced NeuroD1 expression (104),
whereas mice exposed to 3 weeks of chronic mild stress
undergo changes in NeuroD1 expression prevented by
the antidepressant agomelatine (105). Similarly, tempo-
ral lobe Olig2 expression is downregulated in major
depressive disorder (88) whereas antidepressant treat-
ment preventing anhedonia in rodents upregulates Nfib
in the frontal cortex following chronic mild stress (106,
107). It is possible that psychoactive drugs act in part by
modification of accessible chromatin into which GRs
bind, influencing the strength or type of glucocorticoid
response. Equally, symptoms may arise from the impact
of disease on transcription factors assistingGR loading. A
dysregulated HPA axis might influence GR binding in
this manner, as GR binding sites were found in and
around genes for transcription factors linked to motifs
underlying GR binding sites (Supplemental Fig. 3).
Conclusions
We investigated the potential for stress context–dependent
redistribution of GR binding in the hippocampus. We
conclude that reorganizationofGRbinding sites in response
to early stress mediators is not a mechanism for context-
specific glucocorticoid actions in the rat hippocampus.
Alternatively, however, it remains possible that chronic
stress exposure might alter chromatin accessibility in a
manner that could alter GRDNA binding. GR binding was
found within or close to genes governing hippocampal
structural organization, which is profoundly altered in
neuropsychiatric disease. It remains to be seen whether
such sites influence gene expression in acute or chronic
stress paradigms. We additionally show that NF-1 is a
key transcription factor associated with hippocampal
GR binding. Despite displaying some properties ex-
pected of an LDTF, NF-1 half-sites are found within
accessible chromatin from a variety of cell types, arguing
against this role. NF-1 may instead serve as a collabo-
rative or general transcription factor associated with GR
function. bHLH transcription factors are extensively
involved in hippocampal development with appropriate
motifs found at GR binding sites. The motif obtained
may relate to neurons or oligodendrocytes where pre-
vious data imply a lineage-determining role. Conditions
that alter binding of NF-1 or NeuroD1/Olig2 may in-
fluence GR-mediated actions and have consequences for
stress responses and disease susceptibility.
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